● Recruiting

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

Condition: Multiple System Atrophy · Sponsor: Teva Branded Pharmaceutical Products R&D LLC

PhasePhase 2

Planned participants200

Who can joinAll sexes, 30 Years to no upper limit

Healthy volunteersNo

About this study

The primary objective of the trial is to describe the long-term safety and tolerability of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the trial is to further describe the safety and tolerability of TEV-56286. The planned total duration of the trial is approximately 100 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Teva U.S. Medical Information · 1-888-483-8279 · USMedInfo@tevapharm.com

Always discuss trial participation with your own doctor first.

Locations (30)

Teva Investigational Site 15554	La Jolla, California, United States	Recruiting
Teva Investigational Site 15544	Boca Raton, Florida, United States	Recruiting
Teva Investigational Site 15555	Tampa, Florida, United States	Recruiting
Teva Investigational Site 15549	New York, New York, United States	Recruiting
Teva Investigational Site 15551	New York, New York, United States	Recruiting
Teva Investigational Site 15543	Spokane, Washington, United States	Recruiting
Teva Investigational Site 35290	Bordeaux, France	Recruiting
Teva Investigational Site 35291	Paris, France	Recruiting
Teva Investigational Site 35292	Toulouse, France	Recruiting
Teva Investigational Site 32818	Dresden, Germany	Recruiting
Teva Investigational Site 32822	Düsseldorf, Germany	Recruiting
Teva Investigational Site 32825	Kassel, Germany	Recruiting

+ 18 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07197866